← 產業報告目錄
Ophthalmic Drug Delivery System Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 149報告編號 APO-3f6a6ff994
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Ophthalmic Drug Delivery System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ophthalmic Drug Delivery System is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Ophthalmic Drug Delivery System is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, Biocorp Production, Clearside Biomedical, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc. and Gaplast GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ophthalmic Drug Delivery System market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ophthalmic Drug Delivery System Market by Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
Biocorp Production
Clearside Biomedical
Envisia Therapeutics
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Graybug Vision
Kedalion Therapeutics
Mati Therapeutics, Inc.,
Nemera
Nipro Corporation
Ocular Therapeutix
Ocumedic, Inc.
Owen Mumford
Re-Vana Therapeutics
Santen Pharmaceutical
Silgan Holdings Inc.
Taiwan Liposome
Terumo Corporation
West Pharmaceutical Services, Inc.
Ophthalmic Drug Delivery System Segment by Type
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Ophthalmic Drug Delivery System Segment by Application
Clinics
Hospitals
Ambulatory Surgical Centers
Others
Ophthalmic Drug Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ophthalmic Drug Delivery System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ophthalmic Drug Delivery System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ophthalmic Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Ophthalmic Drug Delivery System Market Size (2021-2032)
2.2.2 Global Ophthalmic Drug Delivery System Sales (2021-2032)
2.2.3 Global Ophthalmic Drug Delivery System Market Average Price (2021-2032)
2.3 Ophthalmic Drug Delivery System by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Implantable Ophthalmic Drug Delivery Systems
2.3.3 Particulate Ophthalmic Drug Delivery Systems
2.3.4 Others
2.4 Ophthalmic Drug Delivery System by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Clinics
2.4.3 Hospitals
2.4.4 Ambulatory Surgical Centers
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Ophthalmic Drug Delivery System Sales (k units) of Manufacturers (2021-2026)
3.3 Global Ophthalmic Drug Delivery System Revenue of Manufacturers (2021-2026)
3.4 Global Ophthalmic Drug Delivery System Average Price by Manufacturers (2021-2026)
3.5 Global Ophthalmic Drug Delivery System Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Ophthalmic Drug Delivery System, Product Type & Application
3.8 Global Manufacturers of Ophthalmic Drug Delivery System, Established Date
3.9 Global Ophthalmic Drug Delivery System Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Aero Pump GmbH
4.1.1 Aero Pump GmbH Company Information
4.1.2 Aero Pump GmbH Business Overview
4.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
4.1.5 Aero Pump GmbH Recent Developments
4.2 AptarGroup
4.2.1 AptarGroup Company Information
4.2.2 AptarGroup Business Overview
4.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
4.2.5 AptarGroup Recent Developments
4.3 Bausch Health
4.3.1 Bausch Health Company Information
4.3.2 Bausch Health Business Overview
4.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
4.3.5 Bausch Health Recent Developments
4.4 Becton Dickinson & Company
4.4.1 Becton Dickinson & Company Company Information
4.4.2 Becton Dickinson & Company Business Overview
4.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
4.4.5 Becton Dickinson & Company Recent Developments
4.5 Biocorp Production
4.5.1 Biocorp Production Company Information
4.5.2 Biocorp Production Business Overview
4.5.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
4.5.5 Biocorp Production Recent Developments
4.6 Clearside Biomedical
4.6.1 Clearside Biomedical Company Information
4.6.2 Clearside Biomedical Business Overview
4.6.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
4.6.5 Clearside Biomedical Recent Developments
4.7 Envisia Therapeutics
4.7.1 Envisia Therapeutics Company Information
4.7.2 Envisia Therapeutics Business Overview
4.7.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
4.7.5 Envisia Therapeutics Recent Developments
4.8 EyePoint Pharmaceuticals, Inc.
4.8.1 EyePoint Pharmaceuticals, Inc. Company Information
4.8.2 EyePoint Pharmaceuticals, Inc. Business Overview
4.8.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.8.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
4.8.5 EyePoint Pharmaceuticals, Inc. Recent Developments
4.9 Gaplast GmbH
4.9.1 Gaplast GmbH Company Information
4.9.2 Gaplast GmbH Business Overview
4.9.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
4.9.5 Gaplast GmbH Recent Developments
4.10 Gerresheimer
4.10.1 Gerresheimer Company Information
4.10.2 Gerresheimer Business Overview
4.10.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
4.10.5 Gerresheimer Recent Developments
4.11 Graybug Vision
4.11.1 Graybug Vision Company Information
4.11.2 Graybug Vision Business Overview
4.11.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
4.11.5 Graybug Vision Recent Developments
4.12 Kedalion Therapeutics
4.12.1 Kedalion Therapeutics Company Information
4.12.2 Kedalion Therapeutics Business Overview
4.12.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
4.12.5 Kedalion Therapeutics Recent Developments
4.13 Mati Therapeutics, Inc.,
4.13.1 Mati Therapeutics, Inc., Company Information
4.13.2 Mati Therapeutics, Inc., Business Overview
4.13.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
4.13.5 Mati Therapeutics, Inc., Recent Developments
4.14 Nemera
4.14.1 Nemera Company Information
4.14.2 Nemera Business Overview
4.14.3 Nemera Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
4.14.5 Nemera Recent Developments
4.15 Nipro Corporation
4.15.1 Nipro Corporation Company Information
4.15.2 Nipro Corporation Business Overview
4.15.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
4.15.5 Nipro Corporation Recent Developments
4.16 Ocular Therapeutix
4.16.1 Ocular Therapeutix Company Information
4.16.2 Ocular Therapeutix Business Overview
4.16.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
4.16.5 Ocular Therapeutix Recent Developments
4.17 Ocumedic, Inc.
4.17.1 Ocumedic, Inc. Company Information
4.17.2 Ocumedic, Inc. Business Overview
4.17.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
4.17.5 Ocumedic, Inc. Recent Developments
4.18 Owen Mumford
4.18.1 Owen Mumford Company Information
4.18.2 Owen Mumford Business Overview
4.18.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
4.18.5 Owen Mumford Recent Developments
4.19 Re-Vana Therapeutics
4.19.1 Re-Vana Therapeutics Company Information
4.19.2 Re-Vana Therapeutics Business Overview
4.19.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
4.19.5 Re-Vana Therapeutics Recent Developments
4.20 Santen Pharmaceutical
4.20.1 Santen Pharmaceutical Company Information
4.20.2 Santen Pharmaceutical Business Overview
4.20.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.20.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
4.20.5 Santen Pharmaceutical Recent Developments
4.21 Silgan Holdings Inc.
4.21.1 Silgan Holdings Inc. Company Information
4.21.2 Silgan Holdings Inc. Business Overview
4.21.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.21.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
4.21.5 Silgan Holdings Inc. Recent Developments
4.22 Taiwan Liposome
4.22.1 Taiwan Liposome Company Information
4.22.2 Taiwan Liposome Business Overview
4.22.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.22.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
4.22.5 Taiwan Liposome Recent Developments
4.23 Terumo Corporation
4.23.1 Terumo Corporation Company Information
4.23.2 Terumo Corporation Business Overview
4.23.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.23.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
4.23.5 Terumo Corporation Recent Developments
4.24 West Pharmaceutical Services, Inc.
4.24.1 West Pharmaceutical Services, Inc. Company Information
4.24.2 West Pharmaceutical Services, Inc. Business Overview
4.24.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2021-2026)
4.24.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
4.24.5 West Pharmaceutical Services, Inc. Recent Developments
5 Global Ophthalmic Drug Delivery System Market Scenario by Region
5.1 Global Ophthalmic Drug Delivery System Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Ophthalmic Drug Delivery System Sales by Region: 2021-2032
5.2.1 Global Ophthalmic Drug Delivery System Sales by Region: 2021-2026
5.2.2 Global Ophthalmic Drug Delivery System Sales by Region: 2027-2032
5.3 Global Ophthalmic Drug Delivery System Revenue by Region: 2021-2032
5.3.1 Global Ophthalmic Drug Delivery System Revenue by Region: 2021-2026
5.3.2 Global Ophthalmic Drug Delivery System Revenue by Region: 2027-2032
5.4 North America Ophthalmic Drug Delivery System Market Facts & Figures by Country
5.4.1 North America Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Ophthalmic Drug Delivery System Sales by Country (2021-2032)
5.4.3 North America Ophthalmic Drug Delivery System Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Ophthalmic Drug Delivery System Market Facts & Figures by Country
5.5.1 Europe Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Ophthalmic Drug Delivery System Sales by Country (2021-2032)
5.5.3 Europe Ophthalmic Drug Delivery System Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Ophthalmic Drug Delivery System Market Facts & Figures by Country
5.6.1 Asia Pacific Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Ophthalmic Drug Delivery System Sales by Country (2021-2032)
5.6.3 Asia Pacific Ophthalmic Drug Delivery System Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Ophthalmic Drug Delivery System Market Facts & Figures by Country
5.7.1 South America Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Ophthalmic Drug Delivery System Sales by Country (2021-2032)
5.7.3 South America Ophthalmic Drug Delivery System Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Ophthalmic Drug Delivery System Market Facts & Figures by Country
5.8.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2021-2032)
5.8.3 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Ophthalmic Drug Delivery System Sales by Type (2021-2032)
6.1.1 Global Ophthalmic Drug Delivery System Sales by Type (2021-2032) & (k units)
6.1.2 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2032)
6.2 Global Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
6.2.1 Global Ophthalmic Drug Delivery System Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2032)
6.3 Global Ophthalmic Drug Delivery System Price by Type (2021-2032)
7 Segment by Application
7.1 Global Ophthalmic Drug Delivery System Sales by Application (2021-2032)
7.1.1 Global Ophthalmic Drug Delivery System Sales by Application (2021-2032) & (k units)
7.1.2 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2032)
7.2 Global Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
7.2.1 Global Ophthalmic Drug Delivery System Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2032)
7.3 Global Ophthalmic Drug Delivery System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Ophthalmic Drug Delivery System Value Chain Analysis
8.1.1 Ophthalmic Drug Delivery System Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Ophthalmic Drug Delivery System Production Mode & Process
8.2 Ophthalmic Drug Delivery System Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Ophthalmic Drug Delivery System Distributors
8.2.3 Ophthalmic Drug Delivery System Customers
9 Global Ophthalmic Drug Delivery System Analyzing Market Dynamics
9.1 Ophthalmic Drug Delivery System Industry Trends
9.2 Ophthalmic Drug Delivery System Industry Drivers
9.3 Ophthalmic Drug Delivery System Industry Opportunities and Challenges
9.4 Ophthalmic Drug Delivery System Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Ophthalmic Drug Delivery System Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Ophthalmic Drug Delivery System Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Ophthalmic Drug Delivery System Revenue of Manufacturers (2021-2026)
Table 9. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Ophthalmic Drug Delivery System Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Ophthalmic Drug Delivery System Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Ophthalmic Drug Delivery System, Product Type & Application
Table 14. Global Ophthalmic Drug Delivery System Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Ophthalmic Drug Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Aero Pump GmbH Company Information
Table 19. Aero Pump GmbH Business Overview
Table 20. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
Table 22. Aero Pump GmbH Recent Developments
Table 23. AptarGroup Company Information
Table 24. AptarGroup Business Overview
Table 25. AptarGroup Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. AptarGroup Ophthalmic Drug Delivery System Product Portfolio
Table 27. AptarGroup Recent Developments
Table 28. Bausch Health Company Information
Table 29. Bausch Health Business Overview
Table 30. Bausch Health Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Bausch Health Ophthalmic Drug Delivery System Product Portfolio
Table 32. Bausch Health Recent Developments
Table 33. Becton Dickinson & Company Company Information
Table 34. Becton Dickinson & Company Business Overview
Table 35. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
Table 37. Becton Dickinson & Company Recent Developments
Table 38. Biocorp Production Company Information
Table 39. Biocorp Production Business Overview
Table 40. Biocorp Production Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
Table 42. Biocorp Production Recent Developments
Table 43. Clearside Biomedical Company Information
Table 44. Clearside Biomedical Business Overview
Table 45. Clearside Biomedical Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
Table 47. Clearside Biomedical Recent Developments
Table 48. Envisia Therapeutics Company Information
Table 49. Envisia Therapeutics Business Overview
Table 50. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
Table 52. Envisia Therapeutics Recent Developments
Table 53. EyePoint Pharmaceuticals, Inc. Company Information
Table 54. EyePoint Pharmaceuticals, Inc. Business Overview
Table 55. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
Table 57. EyePoint Pharmaceuticals, Inc. Recent Developments
Table 58. Gaplast GmbH Company Information
Table 59. Gaplast GmbH Business Overview
Table 60. Gaplast GmbH Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
Table 62. Gaplast GmbH Recent Developments
Table 63. Gerresheimer Company Information
Table 64. Gerresheimer Business Overview
Table 65. Gerresheimer Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
Table 67. Gerresheimer Recent Developments
Table 68. Graybug Vision Company Information
Table 69. Graybug Vision Business Overview
Table 70. Graybug Vision Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
Table 72. Graybug Vision Recent Developments
Table 73. Kedalion Therapeutics Company Information
Table 74. Kedalion Therapeutics Business Overview
Table 75. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
Table 77. Kedalion Therapeutics Recent Developments
Table 78. Mati Therapeutics, Inc., Company Information
Table 79. Mati Therapeutics, Inc., Business Overview
Table 80. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
Table 82. Mati Therapeutics, Inc., Recent Developments
Table 83. Nemera Company Information
Table 84. Nemera Business Overview
Table 85. Nemera Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Nemera Ophthalmic Drug Delivery System Product Portfolio
Table 87. Nemera Recent Developments
Table 88. Nipro Corporation Company Information
Table 89. Nipro Corporation Business Overview
Table 90. Nipro Corporation Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
Table 92. Nipro Corporation Recent Developments
Table 93. Ocular Therapeutix Company Information
Table 94. Ocular Therapeutix Business Overview
Table 95. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
Table 97. Ocular Therapeutix Recent Developments
Table 98. Ocumedic, Inc. Company Information
Table 99. Ocumedic, Inc. Business Overview
Table 100. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
Table 102. Ocumedic, Inc. Recent Developments
Table 103. Owen Mumford Company Information
Table 104. Owen Mumford Business Overview
Table 105. Owen Mumford Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
Table 107. Owen Mumford Recent Developments
Table 108. Re-Vana Therapeutics Company Information
Table 109. Re-Vana Therapeutics Business Overview
Table 110. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
Table 112. Re-Vana Therapeutics Recent Developments
Table 113. Santen Pharmaceutical Company Information
Table 114. Santen Pharmaceutical Business Overview
Table 115. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 116. Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
Table 117. Santen Pharmaceutical Recent Developments
Table 118. Silgan Holdings Inc. Company Information
Table 119. Silgan Holdings Inc. Business Overview
Table 120. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 121. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
Table 122. Silgan Holdings Inc. Recent Developments
Table 123. Taiwan Liposome Company Information
Table 124. Taiwan Liposome Business Overview
Table 125. Taiwan Liposome Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 126. Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
Table 127. Taiwan Liposome Recent Developments
Table 128. Terumo Corporation Company Information
Table 129. Terumo Corporation Business Overview
Table 130. Terumo Corporation Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 131. Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
Table 132. Terumo Corporation Recent Developments
Table 133. West Pharmaceutical Services, Inc. Company Information
Table 134. West Pharmaceutical Services, Inc. Business Overview
Table 135. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 136. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
Table 137. West Pharmaceutical Services, Inc. Recent Developments
Table 138. Global Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 139. Global Ophthalmic Drug Delivery System Sales by Region (2021-2026) & (k units)
Table 140. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2026)
Table 141. Global Ophthalmic Drug Delivery System Sales by Region (2027-2032) & (k units)
Table 142. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2027-2032)
Table 143. Global Ophthalmic Drug Delivery System Revenue by Region (2021-2026) & (US$ Million)
Table 144. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2026)
Table 145. Global Ophthalmic Drug Delivery System Revenue by Region (2027-2032) & (US$ Million)
Table 146. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2027-2032)
Table 147. North America Ophthalmic Drug Delivery System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. North America Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units)
Table 149. North America Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units)
Table 150. North America Ophthalmic Drug Delivery System Revenue by Country (2021-2026) & (US$ Million)
Table 151. North America Ophthalmic Drug Delivery System Revenue by Country (2027-2032) & (US$ Million)
Table 152. Europe Ophthalmic Drug Delivery System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Europe Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units)
Table 154. Europe Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units)
Table 155. Europe Ophthalmic Drug Delivery System Revenue by Country (2021-2026) & (US$ Million)
Table 156. Europe Ophthalmic Drug Delivery System Revenue by Country (2027-2032) & (US$ Million)
Table 157. Asia Pacific Ophthalmic Drug Delivery System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. Asia Pacific Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units)
Table 159. Asia Pacific Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units)
Table 160. Asia Pacific Ophthalmic Drug Delivery System Revenue by Country (2021-2026) & (US$ Million)
Table 161. Asia Pacific Ophthalmic Drug Delivery System Revenue by Country (2027-2032) & (US$ Million)
Table 162. South America Ophthalmic Drug Delivery System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. South America Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units)
Table 164. South America Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units)
Table 165. South America Ophthalmic Drug Delivery System Revenue by Country (2021-2026) & (US$ Million)
Table 166. South America Ophthalmic Drug Delivery System Revenue by Country (2027-2032) & (US$ Million)
Table 167. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 168. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units)
Table 169. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units)
Table 170. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2021-2026) & (US$ Million)
Table 171. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2027-2032) & (US$ Million)
Table 172. Global Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units)
Table 173. Global Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units)
Table 174. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2026)
Table 175. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2027-2032)
Table 176. Global Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (US$ Million)
Table 177. Global Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (US$ Million)
Table 178. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2026)
Table 179. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2027-2032)
Table 180. Global Ophthalmic Drug Delivery System Price by Type (2021-2026) & (USD/unit)
Table 181. Global Ophthalmic Drug Delivery System Price by Type (2027-2032) & (USD/unit)
Table 182. Global Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units)
Table 183. Global Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units)
Table 184. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2026)
Table 185. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2027-2032)
Table 186. Global Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (US$ Million)
Table 187. Global Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (US$ Million)
Table 188. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2026)
Table 189. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2027-2032)
Table 190. Global Ophthalmic Drug Delivery System Price by Application (2021-2026) & (USD/unit)
Table 191. Global Ophthalmic Drug Delivery System Price by Application (2027-2032) & (USD/unit)
Table 192. Key Raw Materials
Table 193. Raw Materials Key Suppliers
Table 194. Ophthalmic Drug Delivery System Distributors List
Table 195. Ophthalmic Drug Delivery System Customers List
Table 196. Ophthalmic Drug Delivery System Industry Trends
Table 197. Ophthalmic Drug Delivery System Industry Drivers
Table 198. Ophthalmic Drug Delivery System Industry Restraints
Table 199. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Ophthalmic Drug Delivery System Product Image
Figure 5. Global Ophthalmic Drug Delivery System Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Ophthalmic Drug Delivery System Market Size (2021-2032) & (US$ Million)
Figure 7. Global Ophthalmic Drug Delivery System Sales (2021-2032) & (k units)
Figure 8. Global Ophthalmic Drug Delivery System Average Price (USD/unit) & (2021-2032)
Figure 9. Implantable Ophthalmic Drug Delivery Systems Product Image
Figure 10. Particulate Ophthalmic Drug Delivery Systems Product Image
Figure 11. Others Product Image
Figure 12. Clinics Product Image
Figure 13. Hospitals Product Image
Figure 14. Ambulatory Surgical Centers Product Image
Figure 15. Others Product Image
Figure 16. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Ophthalmic Drug Delivery System Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Ophthalmic Drug Delivery System Sales by Region in 2025
Figure 22. Global Ophthalmic Drug Delivery System Revenue by Region in 2025
Figure 23. North America Ophthalmic Drug Delivery System Market Size by Country in 2025
Figure 24. North America Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032)
Figure 25. North America Ophthalmic Drug Delivery System Revenue Market Share by Country (2021-2032)
Figure 26. United States Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Ophthalmic Drug Delivery System Market Size by Country in 2025
Figure 30. Europe Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032)
Figure 31. Europe Ophthalmic Drug Delivery System Revenue Market Share by Country (2021-2032)
Figure 32. Germany Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Ophthalmic Drug Delivery System Market Size by Country in 2025
Figure 43. Asia Pacific Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Ophthalmic Drug Delivery System Revenue Market Share by Country (2021-2032)
Figure 45. China Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Ophthalmic Drug Delivery System Market Size by Country in 2025
Figure 54. South America Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032)
Figure 55. South America Ophthalmic Drug Delivery System Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country in 2025
Figure 60. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Ophthalmic Drug Delivery System Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Ophthalmic Drug Delivery System Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2032)
Figure 68. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2032)
Figure 69. Global Ophthalmic Drug Delivery System Price (USD/unit) by Type (2021-2032)
Figure 70. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2032)
Figure 71. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2032)
Figure 72. Global Ophthalmic Drug Delivery System Price (USD/unit) by Application (2021-2032)
Figure 73. Ophthalmic Drug Delivery System Value Chain
Figure 74. Ophthalmic Drug Delivery System Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Ophthalmic Drug Delivery System Industry Opportunities and Challenges
提及公司
Aero Pump GmbHAptarGroupBausch HealthBecton Dickinson & CompanyBiocorp ProductionClearside BiomedicalEnvisia TherapeuticsEyePoint Pharmaceuticals, Inc.Gaplast GmbHGerresheimerGraybug VisionKedalion TherapeuticsMati Therapeutics, Inc.,NemeraNipro CorporationOcular TherapeutixOcumedic, Inc.Owen MumfordRe-Vana TherapeuticsSanten PharmaceuticalSilgan Holdings Inc.Taiwan LiposomeTerumo CorporationWest Pharmaceutical Services, Inc.
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們